Daniel Pink

9PUBLICATIONS
57CO-AUTHORS
Major global burdens of diseaseMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPacific Peoples nursing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 28, 2026
The Health-Related Quality of Life of German Desmoid Patients: Results from the PROSa-DES and PROSa Study.

Martin Eichler, Rebekka Hoffmann, Christina Baumgarten

|Jul 29, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

|Nov 11, 2024
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy.

Joseph Tintelnot, Lisa Paschold, Eray Goekkurt

|May 11, 2024
What Is the Impact of Multimodal Treatment in Patients with Leiomyosarcoma of Bone? A Multicenter Study of 35 Patients with an Ultra-Rare Tumor Entity.

Maya Niethard, Carolin Knebel, Andreas Leithner

|Apr 27, 2024
How Do Quality of Life (QoL) and Symptom Burden Evolve in Inpatient Palliative Care (PC) Patients following One Week of Care in a Specialized Palliative Care Unit (PCU)? A Comparison of Two Groups, with One Receiving Specialized Outpatient Palliative Care Prior to Admission.

Hanna Salm, Florian Doberschütz, Franziska Hallmann

|Feb 10, 2024
Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13).

Bernd Kasper, Daniel Pink, Christian Rothermundt

Pageof 2

Frequent Collaborators

5 joint publications

Bernd Kasper

4 joint publications

Peter Hohenberger

3 joint publications

Dimosthenis Andreou

2 joint publications

Martin Eichler